Psychemedics Profit Margin

Psychemedics (PMD) currently reports a profit margin of -9.45% as of December 2024. That compares with -18.8% in the prior-year period — up 49.7% year over year. That is below the Healthcare sector average of 15.52%. Use the charts on this page to explore Psychemedics's profit margin history and peer comparisons.

Psychemedics's profit margin increased from -18.8% to -9.45% — a 49.7% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Psychemedics's profit margin of -9.45% is lower than the Healthcare sector average of 15.52%. That is roughly 160.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Psychemedics's current -9.45% should be judged against Healthcare norms (sector average: 15.52%) and against PMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -9.45%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.52%. From there, open related valuation or income-statement pages for Psychemedics, and consider following PMD for alerts when major investors trade the stock.